Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jéssica Barreto Ribeiro dos Santos, Augusto Afonso Guerra Junior, Michael Ruberson Ribeiro da Silva, Alessandra Maciel Almeida, Francisco de Assis Acurcio & Juliana Alvares-Teodoro. (2019) First line of biological drugs in rheumatoid arthritis: a medication persistence analysis. Expert Review of Clinical Pharmacology 12:4, pages 363-370.
Read now
Read now
Vicki K Wing, Yan Song, Cheryl Xiang, Xinyue Liu, Dendy Macaulay, Maria Ponsillo & William A Blumentals. (2018) Incidence of catheter-related complications among Japanese patients with central venous catheters as well as patients with short bowel syndrome. Clinical and Experimental Gastroenterology 11, pages 439-445.
Read now
Read now
Joerg Mahlich, Akiko Tsubota, Keiichiro Imanaka & Kentaro Enjo. (2018) Burden of illness of chemotherapy in castration-resistant prostate cancer patients in Japan: a retrospective database analysis. Current Medical Research and Opinion 34:10, pages 1855-1860.
Read now
Read now
Jörg Mahlich, Isao Kamae & Rosarin Sruamsiri. (2018) Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 339-348.
Read now
Read now
Articles from other publishers (18)
Richard Conway, Michael S Putman & Sarah L Mackie. (2022) Benchmarking tocilizumab use for giant cell arteritis. Rheumatology Advances in Practice 6:2.
Crossref
Crossref
Yoshiya Tanaka, Tsutomu Takeuchi, Satoshi Soen, Hisashi Yamanaka, Toshiyuki Yoneda, Sakae Tanaka, Takaya Nitta, Naoki Okubo, Harry K. Genant & Désirée van der Heijde. (2021) Effects of Denosumab in Japanese Patients With Rheumatoid Arthritis Treated With Conventional Antirheumatic Drugs: 36-month Extension of a Phase III Study. The Journal of Rheumatology 48:11, pages 1663-1671.
Crossref
Crossref
Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, Tadashi Yokoyama, Masakazu Nagahori, Tomoki Inaba, Mitsuhiro Shikamura, Takayoshi Yamaguchi, Tetsuharu Hori, Philippe Pinton, Mamoru Watanabe & Toshifumi Hibi. (2021) Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis. Intestinal Research 19:4, pages 448-460.
Crossref
Crossref
Yoshiya Tanaka, Satoshi Soen, Naoki Ishiguro, Hisashi Yamanaka, Toshiyuki Yoneda, Sakae Tanaka, Takeshi Ohira, Takaya Nitta, Naoki Okubo, Harry Genant, Desirée van der Heijde & Tsutomu Takeuchi. (2020) Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction. RMD Open 6:2, pages e001249.
Crossref
Crossref
Annalise R. Pfaff, Justin Beltz, Emily King & Nuran Ercal. (2020) Medicinal Thiols: Current Status and New Perspectives. Mini-Reviews in Medicinal Chemistry 20:6, pages 513-529.
Crossref
Crossref
Jörg Tomeczkowski, Sven Dillenburger & Joerg Mahlich. 2020. Digitale Transformation von Dienstleistungen im Gesundheitswesen VII. Digitale Transformation von Dienstleistungen im Gesundheitswesen VII
209
240
.
Jörg Mahlich & Rosarin Sruamsiri. (2019) Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach. International Journal for Equity in Health 18:1.
Crossref
Crossref
Tsutomu Takeuchi, Yoshiya Tanaka, Satoshi Soen, Hisashi Yamanaka, Toshiyuki Yoneda, Sakae Tanaka, Takaya Nitta, Naoki Okubo, Harry K Genant & Désirée van der Heijde. (2019) Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Annals of the Rheumatic Diseases 78:7, pages 899-907.
Crossref
Crossref
Jörg Mahlich, Aranzazu Alba, Laila El Hadad, Marie-Kristin Leisten & Wiebke K. Peitsch. (2019) Drug Survival of Biological Therapies for Psoriasis Treatment in Germany and Associated Costs: A Retrospective Claims Database Analysis. Advances in Therapy 36:7, pages 1684-1699.
Crossref
Crossref
Michael D. George, Brian C. Sauer, Chia-Chen Teng, Grant W. Cannon, Bryant R. England, Gail S. Kerr, Ted R. Mikuls & Joshua F. Baker. (2019) Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis. The Journal of Rheumatology 46:4, pages 343-350.
Crossref
Crossref
Jörg Mahlich, Katsuyoshi Matsuoka & Rosarin Sruamsiri. (2018) Biologic treatment of Japanese patients with inflammatory bowel disease. BMC Gastroenterology 18:1.
Crossref
Crossref
Rosarin Sruamsiri, Hideto Kameda & Jörg Mahlich. (2018) Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs. Drugs - Real World Outcomes 5:3, pages 169-179.
Crossref
Crossref
Rosarin Sruamsiri, Hiroshi Kubo & Jörg Mahlich. (2018) Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus. Medicine 97:29, pages e11491.
Crossref
Crossref
Yoshiya Tanaka & Takeshi Ohira. (2018) Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system. Current Opinion in Pharmacology 40, pages 110-119.
Crossref
Crossref
Stephane Cheung, Yukinobu Hamuro, Jörg Mahlich, Masahiko Nakayama & Akiko Tsubota. (2018) Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data. PLOS ONE 13:4, pages e0195789.
Crossref
Crossref
Berkan Armagan, Alper Sari, Abdulsamet Erden, Levent Kilic, Efe Cem Erdat, Saadettin Kilickap, Sedat Kiraz, Sule Apras Bilgen, Omer Karadag, Ali Akdogan, Ihsan Ertenli & Umut Kalyoncu. (2018) Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity. Medicine 97:13, pages e9930.
Crossref
Crossref
Rosarin Sruamsiri, Yuko Kaneko & Jörg Mahlich. (2017) The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan. BMC Rheumatology 1:1.
Crossref
Crossref
Rosarin Sruamsiri, Sameh Ferchichi, Aurélien Jamotte, Mondher Toumi, Hiroshi Kubo & Jörg Mahlich. (2017) Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach. Influenza and Other Respiratory Viruses 11:6, pages 543-555.
Crossref
Crossref